Operating Cash Flow
Royalty Pharma Operating Cash Flow decreased by 13.2% to $718.23M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.5%, from $596.08M to $718.23M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 5.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $531.72M | $469.76M | $489.96M | $460.27M | $574.95M | $538.83M | $569.93M | $1.03B | $607.82M | $573.52M | $772.63M | $664.64M | $658.21M | $703.61M | $742.53M | $596.08M | $363.98M | $702.62M | $827.15M | $718.23M |
| QoQ Change | — | -11.7% | +4.3% | -6.1% | +24.9% | -6.3% | +5.8% | +81.4% | -41.2% | -5.6% | +34.7% | -14.0% | -1.0% | +6.9% | +5.5% | -19.7% | -38.9% | +93.0% | +17.7% | -13.2% |
| YoY Change | — | — | — | — | +8.1% | +14.7% | +16.3% | +124.6% | +5.7% | +6.4% | +35.6% | -35.7% | +8.3% | +22.7% | -3.9% | -10.3% | -44.7% | -0.1% | +11.4% | +20.5% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's operating cash flow?
- Royalty Pharma (RPRX) reported operating cash flow of $718.23M in Q1 2026.
- How has Royalty Pharma's operating cash flow changed year-over-year?
- Royalty Pharma's operating cash flow increased by 20.5% year-over-year, from $596.08M to $718.23M.
- What is the long-term trend for Royalty Pharma's operating cash flow?
- Over 4 years (2021 to 2025), Royalty Pharma's operating cash flow has grown at a 5.4% compound annual growth rate (CAGR), from $2.02B to $2.49B.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.